Medical device firm ART Advanced Research Technologies of Montreal reported financial results for the company's third quarter.
For the period (end-September 30), ART posted sales of $268,000 (U.S.), compared to $822,000 in the third quarter of 2006. The company's net loss for the most recent quarter was $2.2 million, compared with a net loss of $3.3 million in the corresponding quarter of 2006.
The firm said that during the quarter it began a transition to a new distribution model for its Optix system that involves a mix of direct and indirect sales. The company has also developed a plan for selling its SoftScan breast imaging system in Europe and Canada.
Related Reading
ART wins patent for breast physiology imaging, November 2, 2007
Road to RSNA, Women's Imaging, ART Advanced Research Technologies, October 26, 2007
ART wins purchase promise for SoftScan, October 25, 2007
ART taps DiCamillo for global sales post, September 7, 2007
ART signs Canadian research deal, September 6, 2007
Copyright © 2007 AuntMinnie.com
